P09 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacific Biosciences of California Inc

Watchlist Manager

Watchlist

Price: 1.425 EUR -0.04%

Market Cap: €3.7B

P	Pacific Biosciences of California Inc SWB:P09	US
D	Danaher Corp XETRA:DAP	US
	Yageo Corp TWSE:2327	TW
U	United Labels AG SWB:ULC	DE
M	Mercadolibre Inc F:MLB1	AR
K	Kelly Services Inc NASDAQ:KELYB	US
G	Genuine Parts Co F:GPT	US
G	Grammer AG XHAM:GMM	DE
R	RPM International Inc F:RP8	US
I	Imexpharm Corp VN:IMP	VN

Profitability Summary

Pacific Biosciences of California Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

28%

Gross Margin is Increasing

33% > 40%

Negative Operating Margin

-97%

Negative 3Y Average Operating Margin

-153%

Operating Margin is Increasing

-221% > -97%

Negative Net Margin

-80%

Negative 3Y Average Net Margin

-238%

Net Margin is Increasing

-218% > -80%

Negative Free Cash Flow Margin

-74%

Negative 3Y Average Free Cash Flow Margin

-123%

Free Cash Flow Margin is Increasing

-188% > -74%

Negative ROE

-274%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-34%

Declining ROIC

-33% > -44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.